(Q51501343)

English

Effects of fenofibrate therapy on plasma ubiquinol-10 and ubiquinone-10 levels in Japanese patients with hyperlipidemia and type 2 diabetes mellitus.

scientific article published in April 2006

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

6 April 2018

http://europepmc.org/abstract/MED/16553501

Effects of fenofibrate therapy on plasma ubiquinol-10 and ubiquinone-10 levels in Japanese patients with hyperlipidemia and type 2 diabetes mellitus. (English)

1 reference

Europe PubMed Central

PubMed publication ID

6 April 2018

http://europepmc.org/abstract/MED/16553501

1 reference

based on heuristic

inferred from title

type 2 diabetes

1 reference

based on heuristic

inferred from title

author name string

Akimichi Asano

1

1 reference

Europe PubMed Central

PubMed publication ID

6 April 2018

http://europepmc.org/abstract/MED/16553501

Junji Kobayashi

2

1 reference

Europe PubMed Central

PubMed publication ID

6 April 2018

http://europepmc.org/abstract/MED/16553501

Yuko Murase

3

1 reference

Europe PubMed Central

PubMed publication ID

6 April 2018

http://europepmc.org/abstract/MED/16553501

Atsushi Nohara

4

1 reference

Europe PubMed Central

PubMed publication ID

6 April 2018

http://europepmc.org/abstract/MED/16553501

Masa-Aki Kawashiri

5

1 reference

Europe PubMed Central

PubMed publication ID

6 April 2018

http://europepmc.org/abstract/MED/16553501

Akihiro Inazu

6

1 reference

Europe PubMed Central

PubMed publication ID

6 April 2018

http://europepmc.org/abstract/MED/16553501

Masami Shimizu

7

1 reference

Europe PubMed Central

PubMed publication ID

6 April 2018

http://europepmc.org/abstract/MED/16553501

Hiroshi Mabuchi

8

1 reference

Europe PubMed Central

PubMed publication ID

6 April 2018

http://europepmc.org/abstract/MED/16553501

language of work or name

0 references

publication date

1 April 2006

1 reference

Europe PubMed Central

PubMed publication ID

6 April 2018

http://europepmc.org/abstract/MED/16553501

Pharmacotherapy

1 reference

Europe PubMed Central

PubMed publication ID

6 April 2018

http://europepmc.org/abstract/MED/16553501

26

1 reference

Europe PubMed Central

PubMed publication ID

6 April 2018

http://europepmc.org/abstract/MED/16553501

4

1 reference

Europe PubMed Central

PubMed publication ID

6 April 2018

http://europepmc.org/abstract/MED/16553501

447-451

1 reference

Europe PubMed Central

PubMed publication ID

6 April 2018

http://europepmc.org/abstract/MED/16553501

The participation of coenzyme Q in free radical production and antioxidation

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.26.4.447

21 January 2018

A role for reduced coenzyme Q in atherosclerosis?

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.26.4.447

21 January 2018

Prevention of coronary heart disease with pravastatin in men with hypercholesterolemia. West of Scotland Coronary Prevention Study Group

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.26.4.447

21 January 2018

Evidence of plasma CoQ10-lowering effect by HMG-CoA reductase inhibitors: a double-blind, placebo-controlled study

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.26.4.447

21 January 2018

Combined effect of coenzyme Q10 and fenofibrate on forearm microcirculatory function in type 2 diabetes

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.26.4.447

21 January 2018

Coenzyme Q10 improves blood pressure and glycaemic control: a controlled trial in subjects with type 2 diabetes.

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.26.4.447

21 January 2018

Paradoxical decrease of an adipose-specific protein, adiponectin, in obesity

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.26.4.447

21 January 2018

Simultaneous detection of ubiquinol and ubiquinone in human plasma as a marker of oxidative stress

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.26.4.447

21 January 2018

Influence of peroxisome proliferator-activated receptor alpha on ubiquinone biosynthesis

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.26.4.447

21 January 2018

Beneficial effects of fenofibrate to improve endothelial dysfunction and raise adiponectin levels in patients with primary hypertriglyceridemia

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.26.4.447

21 January 2018

Fenofibrate treatment is associated with better glycemic control and lower serum leptin and insulin levels in type 2 diabetic patients with hypertriglyceridemia.

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.26.4.447

21 January 2018

Benefits of micronised Fenofibrate in type 2 diabetes mellitus subjects with good glycemic control

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.26.4.447

21 January 2018

Identifiers

10.1592/PHCO.26.4.447

1 reference

Europe PubMed Central

PubMed publication ID

6 April 2018

http://europepmc.org/abstract/MED/16553501

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

6 April 2018

http://europepmc.org/abstract/MED/16553501

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q51501343&oldid=1528908944"